Standard biomarkers used for gastric cancer diagnosis include carcinoembryonic antigen (CEA) and cancer antigen 19-9 (CA19-9) (5), however, recently microRNA and DNA hypomethylation have been proposed as novel biomarkers (6,7). This evidence concerns the gene CEACAM5 and gastric cancer.